Medicine:West China Hospital COVID-19 vaccine

From HandWiki
Revision as of 01:31, 5 February 2024 by Rtextdoc (talk | contribs) (link)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Short description: Vaccine candidate against COVID-19
West China Hospital COVID-19 vaccine
Vaccine description
Target diseaseSARS-CoV-2
TypeProtein subunit
Clinical data
Routes of
administration		Intramuscular

West China Hospital COVID-19 vaccine is a COVID-19 vaccine candidate developed by Jiangsu Province Centers for Disease Control and Prevention and West China Hospital.[1][2][3][4]

References

  1. ↑ "A Phase II Clinical Trial of Recombinant Corona Virus Disease-19 (COVID-19) Vaccine (Sf9 Cells)". United States National Library of Medicine. https://clinicaltrials.gov/ct2/show/NCT04640402. 
  2. ↑ "Phase IIb Clinical Trial of Recombinant Novel Coronavirus Pneumonia (COVID-19) Vaccine (Sf9 Cells)". United States National Library of Medicine. https://clinicaltrials.gov/ct2/show/NCT04718467. 
  3. ↑ "Phase I Trial of a Recombinant SARS-CoV-2 Vaccine (Sf9 Cell)". United States National Library of Medicine. https://clinicaltrials.gov/ct2/show/NCT04530656. 
  4. ↑ "A Global Phase III Clinical Trial of Recombinant COVID-19 Vaccine (Sf9 Cells)". clinicaltrials.gov. United States National Library of Medicine. Retrieved 15 May 2021.






Retrieved from "https://handwiki.org/wiki/index.php?title=Medicine:West_China_Hospital_COVID-19_vaccine&oldid=3273165"